Header Logo

Connection

Mignonette Du Plessis to Adult

This is a "connection" page, showing publications Mignonette Du Plessis has written about Adult.
Connection Strength

0,722
  1. Corynebacterium diphtheriae Infections, South Africa, 2015-2023. Emerg Infect Dis. 2025 Mar; 31(3):417-426.
    View in: PubMed
    Score: 0,112
  2. Molecular Characterization of Corynebacterium diphtheriae Outbreak Isolates, South Africa, March-June 2015. Emerg Infect Dis. 2017 08; 23(8):1308-1315.
    View in: PubMed
    Score: 0,066
  3. Phylogenetic Analysis of Invasive Serotype 1 Pneumococcus in South Africa, 1989 to 2013. J Clin Microbiol. 2016 05; 54(5):1326-34.
    View in: PubMed
    Score: 0,060
  4. Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adults. J Infect. 2014 May; 68(5):455-61.
    View in: PubMed
    Score: 0,052
  5. Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa. Int J Antimicrob Agents. 2008 Nov; 32 Suppl 1:S66-70.
    View in: PubMed
    Score: 0,036
  6. Molecular Epidemiology of Invasive Group B Streptococcus in South Africa, 2019-2020. J Infect Dis. 2025 Apr 15; 231(4):e697-e707.
    View in: PubMed
    Score: 0,028
  7. Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project. J Infect. 2025 Mar; 90(3):106426.
    View in: PubMed
    Score: 0,028
  8. Home-Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021-2022-A Pilot Study. Influenza Other Respir Viruses. 2024 12; 18(12):e70034.
    View in: PubMed
    Score: 0,027
  9. Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study. Lancet Glob Health. 2024 Sep; 12(9):e1470-e1484.
    View in: PubMed
    Score: 0,027
  10. Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa. Int J Epidemiol. 2024 Aug 14; 53(5).
    View in: PubMed
    Score: 0,027
  11. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022 01 29; 399(10323):437-446.
    View in: PubMed
    Score: 0,023
  12. Epidemiology of Pertussis in Individuals of All Ages Hospitalized With Respiratory Illness in South Africa, January 2013-December 2018. Clin Infect Dis. 2021 08 02; 73(3):e745-e753.
    View in: PubMed
    Score: 0,022
  13. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021 07; 26(29).
    View in: PubMed
    Score: 0,022
  14. Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016. Clin Infect Dis. 2019 07 18; 69(3):495-504.
    View in: PubMed
    Score: 0,019
  15. Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis. Nat Commun. 2019 05 15; 10(1):2176.
    View in: PubMed
    Score: 0,019
  16. The Fraction of Rhinovirus Detections Attributable to Mild and Severe Respiratory Illness in a Setting of High Human Immunodeficiency Virus Prevalence, South Africa, 2013-2015. J Infect Dis. 2019 05 05; 219(11):1697-1704.
    View in: PubMed
    Score: 0,019
  17. Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015. Emerg Infect Dis. 2018 03; 24(3):506-513.
    View in: PubMed
    Score: 0,017
  18. Invasive Disease Caused Simultaneously by Dual Serotypes of Streptococcus pneumoniae. J Clin Microbiol. 2018 01; 56(1).
    View in: PubMed
    Score: 0,017
  19. Enterovirus genotypes among patients with severe acute respiratory illness, influenza-like illness, and asymptomatic individuals in South Africa, 2012-2014. J Med Virol. 2017 10; 89(10):1759-1767.
    View in: PubMed
    Score: 0,016
  20. Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines. PLoS One. 2014; 9(9):e107666.
    View in: PubMed
    Score: 0,014
  21. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis. 2014 Nov 15; 210(10):1649-57.
    View in: PubMed
    Score: 0,013
  22. HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011. J Infect Dis. 2014 Jan 01; 209(1):56-65.
    View in: PubMed
    Score: 0,013
  23. Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688. J Clin Microbiol. 2012 Nov; 50(11):3678-86.
    View in: PubMed
    Score: 0,012
  24. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa. J Clin Microbiol. 2010 Jun; 48(6):2016-21.
    View in: PubMed
    Score: 0,010
  25. An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa. J Clin Microbiol. 2010 Jan; 48(1):184-91.
    View in: PubMed
    Score: 0,010
  26. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis. 2008 Feb 01; 46(3):377-86.
    View in: PubMed
    Score: 0,009
  27. Prevalence of DHPS polymorphisms associated with sulfa resistance in South African Pneumocystis jirovecii strains. J Eukaryot Microbiol. 2006; 53 Suppl 1:S110-1.
    View in: PubMed
    Score: 0,007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.